nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—EPHX2—Zileuton—asthma	0.157	0.267	CbGbCtD
Sorafenib—UGT1A9—Zileuton—asthma	0.0332	0.0562	CbGbCtD
Sorafenib—UGT1A1—Indacaterol—asthma	0.0327	0.0555	CbGbCtD
Sorafenib—ABCG2—Zafirlukast—asthma	0.0131	0.0223	CbGbCtD
Sorafenib—CYP3A7—Salmeterol—asthma	0.0124	0.021	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Salmeterol—asthma	0.0124	0.021	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Fluticasone Propionate—asthma	0.0105	0.0178	CbGbCtD
Sorafenib—CYP3A7—Fluticasone Propionate—asthma	0.0105	0.0178	CbGbCtD
Sorafenib—CYP3A5—Beclomethasone—asthma	0.00928	0.0157	CbGbCtD
Sorafenib—CYP3A5—Salmeterol—asthma	0.00928	0.0157	CbGbCtD
Sorafenib—CYP2C8—Salmeterol—asthma	0.00892	0.0151	CbGbCtD
Sorafenib—CYP2C8—Mometasone—asthma	0.00892	0.0151	CbGbCtD
Sorafenib—ABCB1—Fluticasone furoate—asthma	0.00797	0.0135	CbGbCtD
Sorafenib—CYP3A5—Fluticasone Propionate—asthma	0.00789	0.0134	CbGbCtD
Sorafenib—CYP2C8—Zafirlukast—asthma	0.007	0.0119	CbGbCtD
Sorafenib—ABCB1—Indacaterol—asthma	0.00649	0.011	CbGbCtD
Sorafenib—CYP1A2—Zileuton—asthma	0.00615	0.0104	CbGbCtD
Sorafenib—CYP2D6—Ciclesonide—asthma	0.00612	0.0104	CbGbCtD
Sorafenib—CYP2C19—Zafirlukast—asthma	0.00587	0.00995	CbGbCtD
Sorafenib—CYP2C19—Arformoterol—asthma	0.00567	0.00961	CbGbCtD
Sorafenib—CYP2C19—Formoterol—asthma	0.00567	0.00961	CbGbCtD
Sorafenib—CYP2C9—Zileuton—asthma	0.00555	0.0094	CbGbCtD
Sorafenib—CYP1A2—Zafirlukast—asthma	0.00542	0.00918	CbGbCtD
Sorafenib—CYP2C8—Theophylline—asthma	0.0054	0.00916	CbGbCtD
Sorafenib—ABCG2—Hydrocortisone—asthma	0.00535	0.00907	CbGbCtD
Sorafenib—CYP2C8—Loratadine—asthma	0.00512	0.00868	CbGbCtD
Sorafenib—CYP2C8—Montelukast—asthma	0.00512	0.00868	CbGbCtD
Sorafenib—CYP2D6—Ipratropium bromide—asthma	0.00507	0.0086	CbGbCtD
Sorafenib—CYP2C9—Zafirlukast—asthma	0.00488	0.00828	CbGbCtD
Sorafenib—CYP3A4—Fluticasone furoate—asthma	0.00477	0.00809	CbGbCtD
Sorafenib—CYP2C9—Arformoterol—asthma	0.00472	0.00799	CbGbCtD
Sorafenib—CYP2C9—Formoterol—asthma	0.00472	0.00799	CbGbCtD
Sorafenib—CYP2D6—Zafirlukast—asthma	0.00446	0.00757	CbGbCtD
Sorafenib—CYP1A2—Aminophylline—asthma	0.00445	0.00754	CbGbCtD
Sorafenib—CYP2D6—Arformoterol—asthma	0.00431	0.00731	CbGbCtD
Sorafenib—CYP2D6—Formoterol—asthma	0.00431	0.00731	CbGbCtD
Sorafenib—CYP2C19—Loratadine—asthma	0.0043	0.00729	CbGbCtD
Sorafenib—CYP3A4—Budesonide—asthma	0.00425	0.00721	CbGbCtD
Sorafenib—CYP1A2—Theophylline—asthma	0.00418	0.00709	CbGbCtD
Sorafenib—CYP3A7—Hydrocortisone—asthma	0.00395	0.0067	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Hydrocortisone—asthma	0.00395	0.0067	CbGbCtD
Sorafenib—CYP3A4—Ciclesonide—asthma	0.00389	0.0066	CbGbCtD
Sorafenib—CYP3A4—Indacaterol—asthma	0.00389	0.0066	CbGbCtD
Sorafenib—CYP2D6—Tiotropium—asthma	0.00384	0.00651	CbGbCtD
Sorafenib—CYP2C9—Theophylline—asthma	0.00377	0.00639	CbGbCtD
Sorafenib—ABCC2—Dexamethasone—asthma	0.00368	0.00624	CbGbCtD
Sorafenib—CYP3A4—Salmeterol—asthma	0.00362	0.00613	CbGbCtD
Sorafenib—CYP3A4—Flunisolide—asthma	0.00362	0.00613	CbGbCtD
Sorafenib—CYP3A4—Salbutamol—asthma	0.00362	0.00613	CbGbCtD
Sorafenib—CYP2C9—Montelukast—asthma	0.00357	0.00606	CbGbCtD
Sorafenib—CYP2C9—Loratadine—asthma	0.00357	0.00606	CbGbCtD
Sorafenib—ABCB1—Loratadine—asthma	0.00347	0.00588	CbGbCtD
Sorafenib—CYP2D6—Theophylline—asthma	0.00345	0.00584	CbGbCtD
Sorafenib—ABCG2—Dexamethasone—asthma	0.00333	0.00564	CbGbCtD
Sorafenib—CYP2D6—Loratadine—asthma	0.00327	0.00554	CbGbCtD
Sorafenib—CYP3A4—Zileuton—asthma	0.00322	0.00547	CbGbCtD
Sorafenib—CYP3A4—Ipratropium bromide—asthma	0.00322	0.00547	CbGbCtD
Sorafenib—ABCB1—Methylprednisolone—asthma	0.00317	0.00538	CbGbCtD
Sorafenib—CYP3A4—Fluticasone Propionate—asthma	0.00308	0.00521	CbGbCtD
Sorafenib—CYP3A5—Hydrocortisone—asthma	0.00296	0.00502	CbGbCtD
Sorafenib—Regorafenib—NTRK1—asthma	0.00295	0.896	CrCbGaD
Sorafenib—CYP2C8—Hydrocortisone—asthma	0.00285	0.00483	CbGbCtD
Sorafenib—CYP3A4—Zafirlukast—asthma	0.00284	0.00481	CbGbCtD
Sorafenib—RET—autonomic nervous system—asthma	0.00277	0.0311	CbGeAlD
Sorafenib—CYP3A7—Dexamethasone—asthma	0.00246	0.00417	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Dexamethasone—asthma	0.00246	0.00417	CbGbCtD
Sorafenib—CYP3A4—Tiotropium—asthma	0.00244	0.00414	CbGbCtD
Sorafenib—CYP2C19—Prednisone—asthma	0.00238	0.00404	CbGbCtD
Sorafenib—CYP2B6—Dexamethasone—asthma	0.00234	0.00397	CbGbCtD
Sorafenib—CYP3A4—Aminophylline—asthma	0.00233	0.00395	CbGbCtD
Sorafenib—CYP3A4—Theophylline—asthma	0.00219	0.00372	CbGbCtD
Sorafenib—CYP3A4—Montelukast—asthma	0.00208	0.00352	CbGbCtD
Sorafenib—CYP3A4—Loratadine—asthma	0.00208	0.00352	CbGbCtD
Sorafenib—ABCB1—Betamethasone—asthma	0.00206	0.0035	CbGbCtD
Sorafenib—ABCB1—Prednisolone—asthma	0.00203	0.00345	CbGbCtD
Sorafenib—CDKL3—cardiovascular system—asthma	0.00197	0.0221	CbGeAlD
Sorafenib—ABCB1—Hydrocortisone—asthma	0.00193	0.00327	CbGbCtD
Sorafenib—ABCB1—Prednisone—asthma	0.00192	0.00326	CbGbCtD
Sorafenib—CYP3A4—Methylprednisolone—asthma	0.0019	0.00322	CbGbCtD
Sorafenib—CYP3A5—Dexamethasone—asthma	0.00184	0.00312	CbGbCtD
Sorafenib—CYP2C8—Dexamethasone—asthma	0.00177	0.003	CbGbCtD
Sorafenib—MAPK15—bronchus—asthma	0.00175	0.0196	CbGeAlD
Sorafenib—CYP2C19—Dexamethasone—asthma	0.00149	0.00252	CbGbCtD
Sorafenib—CYP3A4—Triamcinolone—asthma	0.00144	0.00244	CbGbCtD
Sorafenib—MKNK1—Pindolol—Isoprenaline—asthma	0.00131	1	CbGdCrCtD
Sorafenib—CDK7—respiratory system—asthma	0.00124	0.0139	CbGeAlD
Sorafenib—CYP2C9—Dexamethasone—asthma	0.00124	0.0021	CbGbCtD
Sorafenib—CYP3A4—Betamethasone—asthma	0.00124	0.00209	CbGbCtD
Sorafenib—CYP3A4—Prednisolone—asthma	0.00122	0.00207	CbGbCtD
Sorafenib—ABCB1—Dexamethasone—asthma	0.0012	0.00203	CbGbCtD
Sorafenib—CYP3A4—Hydrocortisone—asthma	0.00116	0.00196	CbGbCtD
Sorafenib—CYP3A4—Prednisone—asthma	0.00115	0.00195	CbGbCtD
Sorafenib—CYP2D6—Dexamethasone—asthma	0.00113	0.00192	CbGbCtD
Sorafenib—ZAK—respiratory system—asthma	0.00107	0.012	CbGeAlD
Sorafenib—MAP3K19—respiratory system—asthma	0.00103	0.0115	CbGeAlD
Sorafenib—TIE1—respiratory system—asthma	0.000978	0.011	CbGeAlD
Sorafenib—KIT—exocrine gland—asthma	0.000904	0.0101	CbGeAlD
Sorafenib—FLT3—respiratory system—asthma	0.00089	0.00998	CbGeAlD
Sorafenib—ZAK—bronchus—asthma	0.00088	0.00987	CbGeAlD
Sorafenib—HIPK3—bronchus—asthma	0.000861	0.00966	CbGeAlD
Sorafenib—TIE1—adrenal cortex—asthma	0.000821	0.00921	CbGeAlD
Sorafenib—ZAK—cardiovascular system—asthma	0.000819	0.00919	CbGeAlD
Sorafenib—TIE1—epithelium—asthma	0.000818	0.00917	CbGeAlD
Sorafenib—FLT4—respiratory system—asthma	0.000808	0.00907	CbGeAlD
Sorafenib—HIPK3—cardiovascular system—asthma	0.000802	0.00899	CbGeAlD
Sorafenib—TIE1—smooth muscle tissue—asthma	0.000788	0.00883	CbGeAlD
Sorafenib—MAPK11—adrenal gland—asthma	0.000762	0.00855	CbGeAlD
Sorafenib—EPHX2—adrenal cortex—asthma	0.000752	0.00844	CbGeAlD
Sorafenib—CDK7—adrenal gland—asthma	0.00075	0.00841	CbGeAlD
Sorafenib—TIE1—cardiovascular system—asthma	0.000749	0.0084	CbGeAlD
Sorafenib—TAOK2—adrenal gland—asthma	0.000744	0.00834	CbGeAlD
Sorafenib—AURKC—adrenal gland—asthma	0.000738	0.00828	CbGeAlD
Sorafenib—MKNK2—respiratory system—asthma	0.000732	0.00821	CbGeAlD
Sorafenib—CYP3A4—Dexamethasone—asthma	0.000719	0.00122	CbGbCtD
Sorafenib—FLT3—cardiovascular system—asthma	0.000682	0.00765	CbGeAlD
Sorafenib—FLT4—adrenal cortex—asthma	0.000678	0.00761	CbGeAlD
Sorafenib—FLT4—epithelium—asthma	0.000676	0.00758	CbGeAlD
Sorafenib—RALBP1—respiratory system—asthma	0.000661	0.00741	CbGeAlD
Sorafenib—CDK7—lung—asthma	0.000657	0.00737	CbGeAlD
Sorafenib—FGFR1—bronchus—asthma	0.000656	0.00736	CbGeAlD
Sorafenib—TAOK2—lung—asthma	0.000652	0.00731	CbGeAlD
Sorafenib—ZAK—adrenal gland—asthma	0.000648	0.00727	CbGeAlD
Sorafenib—HIPK3—adrenal gland—asthma	0.000634	0.00711	CbGeAlD
Sorafenib—MAP3K7—adrenal cortex—asthma	0.000634	0.00711	CbGeAlD
Sorafenib—FLT1—respiratory system—asthma	0.000629	0.00705	CbGeAlD
Sorafenib—RAF1—respiratory system—asthma	0.000625	0.00701	CbGeAlD
Sorafenib—MAP3K7—bronchus—asthma	0.000621	0.00697	CbGeAlD
Sorafenib—FLT4—cardiovascular system—asthma	0.000619	0.00694	CbGeAlD
Sorafenib—MKNK2—adrenal cortex—asthma	0.000614	0.00689	CbGeAlD
Sorafenib—MKNK2—epithelium—asthma	0.000611	0.00686	CbGeAlD
Sorafenib—MAP3K7—smooth muscle tissue—asthma	0.000608	0.00682	CbGeAlD
Sorafenib—MKNK1—adrenal cortex—asthma	0.000606	0.0068	CbGeAlD
Sorafenib—MKNK2—bronchus—asthma	0.000602	0.00675	CbGeAlD
Sorafenib—RET—epithelium—asthma	0.000596	0.00669	CbGeAlD
Sorafenib—STK10—respiratory system—asthma	0.000595	0.00667	CbGeAlD
Sorafenib—MKNK1—bronchus—asthma	0.000595	0.00667	CbGeAlD
Sorafenib—TIE1—adrenal gland—asthma	0.000593	0.00665	CbGeAlD
Sorafenib—MKNK2—smooth muscle tissue—asthma	0.000589	0.00661	CbGeAlD
Sorafenib—PDGFRA—respiratory system—asthma	0.000589	0.00661	CbGeAlD
Sorafenib—BRAF—adrenal gland—asthma	0.000568	0.00637	CbGeAlD
Sorafenib—ZAK—lung—asthma	0.000568	0.00637	CbGeAlD
Sorafenib—MKNK2—cardiovascular system—asthma	0.00056	0.00629	CbGeAlD
Sorafenib—MAP3K7—trachea—asthma	0.000558	0.00626	CbGeAlD
Sorafenib—HIPK3—lung—asthma	0.000556	0.00623	CbGeAlD
Sorafenib—RALBP1—adrenal cortex—asthma	0.000555	0.00622	CbGeAlD
Sorafenib—MKNK1—cardiovascular system—asthma	0.000553	0.00621	CbGeAlD
Sorafenib—MAP3K19—lung—asthma	0.000544	0.00611	CbGeAlD
Sorafenib—RALBP1—bronchus—asthma	0.000544	0.0061	CbGeAlD
Sorafenib—EPHX2—adrenal gland—asthma	0.000543	0.00609	CbGeAlD
Sorafenib—MKNK2—trachea—asthma	0.000541	0.00606	CbGeAlD
Sorafenib—FLT3—adrenal gland—asthma	0.000539	0.00605	CbGeAlD
Sorafenib—RALBP1—smooth muscle tissue—asthma	0.000532	0.00597	CbGeAlD
Sorafenib—KDR—respiratory system—asthma	0.000531	0.00596	CbGeAlD
Sorafenib—FLT1—adrenal cortex—asthma	0.000527	0.00592	CbGeAlD
Sorafenib—FLT1—epithelium—asthma	0.000525	0.00589	CbGeAlD
Sorafenib—RAF1—adrenal cortex—asthma	0.000524	0.00588	CbGeAlD
Sorafenib—RAF1—epithelium—asthma	0.000522	0.00586	CbGeAlD
Sorafenib—TIE1—lung—asthma	0.000519	0.00583	CbGeAlD
Sorafenib—CSF1R—respiratory system—asthma	0.000519	0.00582	CbGeAlD
Sorafenib—FLT1—bronchus—asthma	0.000517	0.0058	CbGeAlD
Sorafenib—RAF1—bronchus—asthma	0.000514	0.00577	CbGeAlD
Sorafenib—EPHB6—bronchus—asthma	0.000511	0.00573	CbGeAlD
Sorafenib—FLT1—smooth muscle tissue—asthma	0.000506	0.00568	CbGeAlD
Sorafenib—RALBP1—cardiovascular system—asthma	0.000506	0.00568	CbGeAlD
Sorafenib—RAF1—smooth muscle tissue—asthma	0.000503	0.00564	CbGeAlD
Sorafenib—BRAF—lung—asthma	0.000498	0.00559	CbGeAlD
Sorafenib—FLT4—adrenal gland—asthma	0.00049	0.00549	CbGeAlD
Sorafenib—STK10—bronchus—asthma	0.00049	0.00549	CbGeAlD
Sorafenib—RALBP1—trachea—asthma	0.000488	0.00548	CbGeAlD
Sorafenib—FGFR1—adrenal gland—asthma	0.000483	0.00542	CbGeAlD
Sorafenib—FLT1—cardiovascular system—asthma	0.000481	0.0054	CbGeAlD
Sorafenib—RAF1—cardiovascular system—asthma	0.000479	0.00537	CbGeAlD
Sorafenib—EPHX2—lung—asthma	0.000476	0.00534	CbGeAlD
Sorafenib—PDGFRA—smooth muscle tissue—asthma	0.000474	0.00532	CbGeAlD
Sorafenib—FLT3—lung—asthma	0.000473	0.0053	CbGeAlD
Sorafenib—KIT—respiratory system—asthma	0.000471	0.00528	CbGeAlD
Sorafenib—FLT1—trachea—asthma	0.000464	0.00521	CbGeAlD
Sorafenib—RAF1—trachea—asthma	0.000462	0.00518	CbGeAlD
Sorafenib—PDGFRB—respiratory system—asthma	0.00046	0.00516	CbGeAlD
Sorafenib—EPHB6—trachea—asthma	0.000459	0.00515	CbGeAlD
Sorafenib—MAP3K7—adrenal gland—asthma	0.000457	0.00513	CbGeAlD
Sorafenib—STK10—cardiovascular system—asthma	0.000456	0.00511	CbGeAlD
Sorafenib—PDGFRA—cardiovascular system—asthma	0.000451	0.00506	CbGeAlD
Sorafenib—MAP2K5—adrenal cortex—asthma	0.000446	0.005	CbGeAlD
Sorafenib—KDR—adrenal cortex—asthma	0.000446	0.005	CbGeAlD
Sorafenib—KDR—epithelium—asthma	0.000444	0.00498	CbGeAlD
Sorafenib—MKNK2—adrenal gland—asthma	0.000443	0.00497	CbGeAlD
Sorafenib—MKNK1—adrenal gland—asthma	0.000438	0.00491	CbGeAlD
Sorafenib—MAP2K5—bronchus—asthma	0.000437	0.0049	CbGeAlD
Sorafenib—KDR—bronchus—asthma	0.000437	0.0049	CbGeAlD
Sorafenib—PDGFRA—trachea—asthma	0.000435	0.00488	CbGeAlD
Sorafenib—CSF1R—adrenal cortex—asthma	0.000435	0.00488	CbGeAlD
Sorafenib—RET—adrenal gland—asthma	0.000432	0.00485	CbGeAlD
Sorafenib—FLT4—lung—asthma	0.000429	0.00481	CbGeAlD
Sorafenib—KDR—smooth muscle tissue—asthma	0.000428	0.0048	CbGeAlD
Sorafenib—CSF1R—bronchus—asthma	0.000427	0.00479	CbGeAlD
Sorafenib—FGFR1—lung—asthma	0.000423	0.00475	CbGeAlD
Sorafenib—CSF1R—smooth muscle tissue—asthma	0.000418	0.00468	CbGeAlD
Sorafenib—KDR—cardiovascular system—asthma	0.000407	0.00456	CbGeAlD
Sorafenib—MAP2K5—cardiovascular system—asthma	0.000407	0.00456	CbGeAlD
Sorafenib—MAP3K7—lung—asthma	0.000401	0.0045	CbGeAlD
Sorafenib—RALBP1—adrenal gland—asthma	0.0004	0.00449	CbGeAlD
Sorafenib—CSF1R—cardiovascular system—asthma	0.000397	0.00445	CbGeAlD
Sorafenib—KIT—epithelium—asthma	0.000393	0.00441	CbGeAlD
Sorafenib—MAP2K5—trachea—asthma	0.000393	0.0044	CbGeAlD
Sorafenib—KDR—trachea—asthma	0.000393	0.0044	CbGeAlD
Sorafenib—MKNK2—lung—asthma	0.000389	0.00436	CbGeAlD
Sorafenib—KIT—bronchus—asthma	0.000387	0.00435	CbGeAlD
Sorafenib—PDGFRB—adrenal cortex—asthma	0.000386	0.00433	CbGeAlD
Sorafenib—PDGFRB—epithelium—asthma	0.000384	0.00431	CbGeAlD
Sorafenib—MKNK1—lung—asthma	0.000384	0.0043	CbGeAlD
Sorafenib—CSF1R—trachea—asthma	0.000383	0.0043	CbGeAlD
Sorafenib—FLT1—adrenal gland—asthma	0.000381	0.00427	CbGeAlD
Sorafenib—KIT—smooth muscle tissue—asthma	0.000379	0.00425	CbGeAlD
Sorafenib—RAF1—adrenal gland—asthma	0.000379	0.00425	CbGeAlD
Sorafenib—PDGFRB—bronchus—asthma	0.000378	0.00424	CbGeAlD
Sorafenib—EPHB6—adrenal gland—asthma	0.000376	0.00422	CbGeAlD
Sorafenib—PDGFRB—smooth muscle tissue—asthma	0.00037	0.00415	CbGeAlD
Sorafenib—KIT—cardiovascular system—asthma	0.000361	0.00404	CbGeAlD
Sorafenib—STK10—adrenal gland—asthma	0.00036	0.00404	CbGeAlD
Sorafenib—PDGFRA—adrenal gland—asthma	0.000357	0.004	CbGeAlD
Sorafenib—PDGFRB—cardiovascular system—asthma	0.000352	0.00395	CbGeAlD
Sorafenib—RALBP1—lung—asthma	0.000351	0.00394	CbGeAlD
Sorafenib—KIT—trachea—asthma	0.000348	0.0039	CbGeAlD
Sorafenib—Vismodegib—ALB—asthma	0.000343	0.104	CrCbGaD
Sorafenib—PDGFRB—trachea—asthma	0.00034	0.00381	CbGeAlD
Sorafenib—FLT1—lung—asthma	0.000334	0.00374	CbGeAlD
Sorafenib—RAF1—lung—asthma	0.000332	0.00372	CbGeAlD
Sorafenib—EPHB6—lung—asthma	0.00033	0.0037	CbGeAlD
Sorafenib—KDR—adrenal gland—asthma	0.000322	0.00361	CbGeAlD
Sorafenib—MAP2K5—adrenal gland—asthma	0.000322	0.00361	CbGeAlD
Sorafenib—STK10—lung—asthma	0.000316	0.00354	CbGeAlD
Sorafenib—CSF1R—adrenal gland—asthma	0.000314	0.00352	CbGeAlD
Sorafenib—PDGFRA—lung—asthma	0.000313	0.00351	CbGeAlD
Sorafenib—HTR2B—adrenal cortex—asthma	0.000306	0.00343	CbGeAlD
Sorafenib—ABCC4—bronchus—asthma	0.000301	0.00338	CbGeAlD
Sorafenib—HTR2B—smooth muscle tissue—asthma	0.000293	0.00329	CbGeAlD
Sorafenib—KIT—adrenal gland—asthma	0.000285	0.0032	CbGeAlD
Sorafenib—MAP2K5—lung—asthma	0.000282	0.00316	CbGeAlD
Sorafenib—KDR—lung—asthma	0.000282	0.00316	CbGeAlD
Sorafenib—HTR2B—cardiovascular system—asthma	0.000279	0.00313	CbGeAlD
Sorafenib—PDGFRB—adrenal gland—asthma	0.000279	0.00312	CbGeAlD
Sorafenib—CSF1R—lung—asthma	0.000275	0.00309	CbGeAlD
Sorafenib—KIT—lung—asthma	0.00025	0.0028	CbGeAlD
Sorafenib—CYP1A2—respiratory system—asthma	0.000249	0.00279	CbGeAlD
Sorafenib—PDGFRB—lung—asthma	0.000244	0.00274	CbGeAlD
Sorafenib—CYP3A5—respiratory system—asthma	0.00024	0.00269	CbGeAlD
Sorafenib—CYP2B6—respiratory system—asthma	0.000238	0.00267	CbGeAlD
Sorafenib—ABCC4—adrenal gland—asthma	0.000222	0.00249	CbGeAlD
Sorafenib—HTR2B—adrenal gland—asthma	0.000221	0.00247	CbGeAlD
Sorafenib—ABCG2—adrenal cortex—asthma	0.000217	0.00243	CbGeAlD
Sorafenib—ABCC2—adrenal gland—asthma	0.000215	0.00241	CbGeAlD
Sorafenib—CYP2B6—adrenal cortex—asthma	0.0002	0.00224	CbGeAlD
Sorafenib—CYP2B6—bronchus—asthma	0.000196	0.0022	CbGeAlD
Sorafenib—ABCC4—lung—asthma	0.000194	0.00218	CbGeAlD
Sorafenib—HTR2B—lung—asthma	0.000193	0.00217	CbGeAlD
Sorafenib—CYP2B6—cardiovascular system—asthma	0.000183	0.00205	CbGeAlD
Sorafenib—CYP2C9—cardiovascular system—asthma	0.000181	0.00203	CbGeAlD
Sorafenib—ABCG2—adrenal gland—asthma	0.000157	0.00176	CbGeAlD
Sorafenib—CYP2B6—adrenal gland—asthma	0.000144	0.00162	CbGeAlD
Sorafenib—ABCG2—lung—asthma	0.000137	0.00154	CbGeAlD
Sorafenib—CYP1A2—lung—asthma	0.000132	0.00148	CbGeAlD
Sorafenib—ABCB1—respiratory system—asthma	0.000127	0.00143	CbGeAlD
Sorafenib—CYP3A5—lung—asthma	0.000127	0.00143	CbGeAlD
Sorafenib—CYP2B6—lung—asthma	0.000127	0.00142	CbGeAlD
Sorafenib—ABCB1—adrenal cortex—asthma	0.000107	0.0012	CbGeAlD
Sorafenib—ABCB1—epithelium—asthma	0.000107	0.00119	CbGeAlD
Sorafenib—ABCB1—cardiovascular system—asthma	9.76e-05	0.00109	CbGeAlD
Sorafenib—ABCB1—trachea—asthma	9.42e-05	0.00106	CbGeAlD
Sorafenib—ABCB1—adrenal gland—asthma	7.72e-05	0.000866	CbGeAlD
Sorafenib—ABCB1—lung—asthma	6.77e-05	0.000759	CbGeAlD
Sorafenib—Rash—Arformoterol—asthma	4.99e-05	0.000287	CcSEcCtD
Sorafenib—Rash—Formoterol—asthma	4.99e-05	0.000287	CcSEcCtD
Sorafenib—Mediastinal disorder—Methylprednisolone—asthma	4.99e-05	0.000287	CcSEcCtD
Sorafenib—Dermatitis—Formoterol—asthma	4.98e-05	0.000287	CcSEcCtD
Sorafenib—Dermatitis—Arformoterol—asthma	4.98e-05	0.000287	CcSEcCtD
Sorafenib—Headache—Formoterol—asthma	4.95e-05	0.000285	CcSEcCtD
Sorafenib—Headache—Arformoterol—asthma	4.95e-05	0.000285	CcSEcCtD
Sorafenib—Arrhythmia—Triamcinolone—asthma	4.95e-05	0.000285	CcSEcCtD
Sorafenib—Weight decreased—Prednisone—asthma	4.95e-05	0.000285	CcSEcCtD
Sorafenib—Diarrhoea—Budesonide—asthma	4.95e-05	0.000285	CcSEcCtD
Sorafenib—Arrhythmia—Methylprednisolone—asthma	4.94e-05	0.000285	CcSEcCtD
Sorafenib—Dizziness—Salbutamol—asthma	4.94e-05	0.000284	CcSEcCtD
Sorafenib—Vomiting—Montelukast—asthma	4.92e-05	0.000284	CcSEcCtD
Sorafenib—Rash—Montelukast—asthma	4.88e-05	0.000281	CcSEcCtD
Sorafenib—Dermatitis—Montelukast—asthma	4.88e-05	0.000281	CcSEcCtD
Sorafenib—Headache—Montelukast—asthma	4.85e-05	0.00028	CcSEcCtD
Sorafenib—Mental disorder—Methylprednisolone—asthma	4.85e-05	0.000279	CcSEcCtD
Sorafenib—Erythema—Triamcinolone—asthma	4.83e-05	0.000278	CcSEcCtD
Sorafenib—Malnutrition—Methylprednisolone—asthma	4.82e-05	0.000277	CcSEcCtD
Sorafenib—Erythema—Methylprednisolone—asthma	4.82e-05	0.000277	CcSEcCtD
Sorafenib—Acute coronary syndrome—Prednisone—asthma	4.81e-05	0.000277	CcSEcCtD
Sorafenib—Angioedema—Prednisolone—asthma	4.8e-05	0.000276	CcSEcCtD
Sorafenib—Myocardial infarction—Prednisone—asthma	4.78e-05	0.000276	CcSEcCtD
Sorafenib—Neuropathy peripheral—Prednisone—asthma	4.78e-05	0.000276	CcSEcCtD
Sorafenib—Dizziness—Budesonide—asthma	4.78e-05	0.000276	CcSEcCtD
Sorafenib—Vomiting—Salbutamol—asthma	4.75e-05	0.000274	CcSEcCtD
Sorafenib—Dysgeusia—Triamcinolone—asthma	4.73e-05	0.000272	CcSEcCtD
Sorafenib—Rash—Salbutamol—asthma	4.71e-05	0.000271	CcSEcCtD
Sorafenib—Syncope—Prednisolone—asthma	4.71e-05	0.000271	CcSEcCtD
Sorafenib—Dermatitis—Salbutamol—asthma	4.7e-05	0.000271	CcSEcCtD
Sorafenib—Nausea—Formoterol—asthma	4.7e-05	0.000271	CcSEcCtD
Sorafenib—Nausea—Arformoterol—asthma	4.7e-05	0.000271	CcSEcCtD
Sorafenib—Angioedema—Hydrocortisone—asthma	4.68e-05	0.00027	CcSEcCtD
Sorafenib—Headache—Salbutamol—asthma	4.68e-05	0.00027	CcSEcCtD
Sorafenib—Loss of consciousness—Prednisolone—asthma	4.61e-05	0.000266	CcSEcCtD
Sorafenib—Nausea—Montelukast—asthma	4.6e-05	0.000265	CcSEcCtD
Sorafenib—Vomiting—Budesonide—asthma	4.6e-05	0.000265	CcSEcCtD
Sorafenib—Syncope—Hydrocortisone—asthma	4.6e-05	0.000265	CcSEcCtD
Sorafenib—Angiopathy—Dexamethasone—asthma	4.56e-05	0.000263	CcSEcCtD
Sorafenib—Angiopathy—Betamethasone—asthma	4.56e-05	0.000263	CcSEcCtD
Sorafenib—Rash—Budesonide—asthma	4.56e-05	0.000263	CcSEcCtD
Sorafenib—Dermatitis—Budesonide—asthma	4.56e-05	0.000263	CcSEcCtD
Sorafenib—Headache—Budesonide—asthma	4.53e-05	0.000261	CcSEcCtD
Sorafenib—Hypertension—Prednisolone—asthma	4.53e-05	0.000261	CcSEcCtD
Sorafenib—Loss of consciousness—Hydrocortisone—asthma	4.5e-05	0.00026	CcSEcCtD
Sorafenib—Arrhythmia—Betamethasone—asthma	4.49e-05	0.000259	CcSEcCtD
Sorafenib—Arrhythmia—Dexamethasone—asthma	4.49e-05	0.000259	CcSEcCtD
Sorafenib—Alopecia—Dexamethasone—asthma	4.44e-05	0.000256	CcSEcCtD
Sorafenib—Alopecia—Betamethasone—asthma	4.44e-05	0.000256	CcSEcCtD
Sorafenib—Nausea—Salbutamol—asthma	4.44e-05	0.000256	CcSEcCtD
Sorafenib—Hypertension—Hydrocortisone—asthma	4.42e-05	0.000255	CcSEcCtD
Sorafenib—Angioedema—Triamcinolone—asthma	4.41e-05	0.000254	CcSEcCtD
Sorafenib—Haemoglobin—Prednisone—asthma	4.4e-05	0.000254	CcSEcCtD
Sorafenib—Angioedema—Methylprednisolone—asthma	4.4e-05	0.000253	CcSEcCtD
Sorafenib—Haemorrhage—Prednisone—asthma	4.38e-05	0.000252	CcSEcCtD
Sorafenib—Erythema—Dexamethasone—asthma	4.38e-05	0.000252	CcSEcCtD
Sorafenib—Erythema—Betamethasone—asthma	4.38e-05	0.000252	CcSEcCtD
Sorafenib—Myalgia—Hydrocortisone—asthma	4.36e-05	0.000251	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.33e-05	0.00025	CcSEcCtD
Sorafenib—Syncope—Triamcinolone—asthma	4.33e-05	0.000249	CcSEcCtD
Sorafenib—Syncope—Methylprednisolone—asthma	4.32e-05	0.000249	CcSEcCtD
Sorafenib—Connective tissue disorder—Prednisone—asthma	4.3e-05	0.000248	CcSEcCtD
Sorafenib—Nausea—Budesonide—asthma	4.3e-05	0.000248	CcSEcCtD
Sorafenib—Anaphylactic shock—Prednisolone—asthma	4.28e-05	0.000247	CcSEcCtD
Sorafenib—Loss of consciousness—Triamcinolone—asthma	4.24e-05	0.000244	CcSEcCtD
Sorafenib—Loss of consciousness—Methylprednisolone—asthma	4.23e-05	0.000244	CcSEcCtD
Sorafenib—Shock—Prednisolone—asthma	4.21e-05	0.000243	CcSEcCtD
Sorafenib—Cough—Triamcinolone—asthma	4.21e-05	0.000243	CcSEcCtD
Sorafenib—Anaphylactic shock—Hydrocortisone—asthma	4.18e-05	0.000241	CcSEcCtD
Sorafenib—Hypertension—Triamcinolone—asthma	4.17e-05	0.00024	CcSEcCtD
Sorafenib—Hypertension—Methylprednisolone—asthma	4.16e-05	0.00024	CcSEcCtD
Sorafenib—Infection—Hydrocortisone—asthma	4.16e-05	0.000239	CcSEcCtD
Sorafenib—Shock—Hydrocortisone—asthma	4.12e-05	0.000237	CcSEcCtD
Sorafenib—Myalgia—Triamcinolone—asthma	4.11e-05	0.000237	CcSEcCtD
Sorafenib—Nervous system disorder—Hydrocortisone—asthma	4.1e-05	0.000236	CcSEcCtD
Sorafenib—Arthralgia—Methylprednisolone—asthma	4.1e-05	0.000236	CcSEcCtD
Sorafenib—Myalgia—Methylprednisolone—asthma	4.1e-05	0.000236	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.07e-05	0.000235	CcSEcCtD
Sorafenib—Flushing—Prednisone—asthma	4.07e-05	0.000234	CcSEcCtD
Sorafenib—Skin disorder—Hydrocortisone—asthma	4.06e-05	0.000234	CcSEcCtD
Sorafenib—Dry mouth—Triamcinolone—asthma	4.02e-05	0.000232	CcSEcCtD
Sorafenib—Angioedema—Betamethasone—asthma	4e-05	0.000231	CcSEcCtD
Sorafenib—Angioedema—Dexamethasone—asthma	4e-05	0.000231	CcSEcCtD
Sorafenib—Anorexia—Hydrocortisone—asthma	3.99e-05	0.00023	CcSEcCtD
Sorafenib—Angiopathy—Prednisone—asthma	3.97e-05	0.000229	CcSEcCtD
Sorafenib—Immune system disorder—Prednisone—asthma	3.96e-05	0.000228	CcSEcCtD
Sorafenib—Anaphylactic shock—Triamcinolone—asthma	3.94e-05	0.000227	CcSEcCtD
Sorafenib—Anaphylactic shock—Methylprednisolone—asthma	3.93e-05	0.000226	CcSEcCtD
Sorafenib—Syncope—Betamethasone—asthma	3.93e-05	0.000226	CcSEcCtD
Sorafenib—Syncope—Dexamethasone—asthma	3.93e-05	0.000226	CcSEcCtD
Sorafenib—Arrhythmia—Prednisone—asthma	3.91e-05	0.000225	CcSEcCtD
Sorafenib—Infection—Triamcinolone—asthma	3.91e-05	0.000225	CcSEcCtD
Sorafenib—Infection—Methylprednisolone—asthma	3.9e-05	0.000225	CcSEcCtD
Sorafenib—Shock—Triamcinolone—asthma	3.87e-05	0.000223	CcSEcCtD
Sorafenib—Alopecia—Prednisone—asthma	3.87e-05	0.000223	CcSEcCtD
Sorafenib—Shock—Methylprednisolone—asthma	3.87e-05	0.000223	CcSEcCtD
Sorafenib—Nervous system disorder—Methylprednisolone—asthma	3.85e-05	0.000222	CcSEcCtD
Sorafenib—Loss of consciousness—Betamethasone—asthma	3.85e-05	0.000222	CcSEcCtD
Sorafenib—Loss of consciousness—Dexamethasone—asthma	3.85e-05	0.000222	CcSEcCtD
Sorafenib—Mental disorder—Prednisone—asthma	3.84e-05	0.000221	CcSEcCtD
Sorafenib—Skin disorder—Methylprednisolone—asthma	3.82e-05	0.00022	CcSEcCtD
Sorafenib—Erythema—Prednisone—asthma	3.81e-05	0.00022	CcSEcCtD
Sorafenib—Malnutrition—Prednisone—asthma	3.81e-05	0.00022	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Hydrocortisone—asthma	3.81e-05	0.00022	CcSEcCtD
Sorafenib—Hypertension—Dexamethasone—asthma	3.78e-05	0.000218	CcSEcCtD
Sorafenib—Hypertension—Betamethasone—asthma	3.78e-05	0.000218	CcSEcCtD
Sorafenib—Myalgia—Betamethasone—asthma	3.73e-05	0.000215	CcSEcCtD
Sorafenib—Myalgia—Dexamethasone—asthma	3.73e-05	0.000215	CcSEcCtD
Sorafenib—Dyspepsia—Hydrocortisone—asthma	3.68e-05	0.000212	CcSEcCtD
Sorafenib—Pain—Prednisolone—asthma	3.66e-05	0.000211	CcSEcCtD
Sorafenib—Decreased appetite—Hydrocortisone—asthma	3.64e-05	0.000209	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Hydrocortisone—asthma	3.61e-05	0.000208	CcSEcCtD
Sorafenib—Fatigue—Hydrocortisone—asthma	3.61e-05	0.000208	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Triamcinolone—asthma	3.59e-05	0.000207	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Methylprednisolone—asthma	3.58e-05	0.000206	CcSEcCtD
Sorafenib—Pain—Hydrocortisone—asthma	3.58e-05	0.000206	CcSEcCtD
Sorafenib—Anaphylactic shock—Dexamethasone—asthma	3.57e-05	0.000206	CcSEcCtD
Sorafenib—Anaphylactic shock—Betamethasone—asthma	3.57e-05	0.000206	CcSEcCtD
Sorafenib—Infection—Dexamethasone—asthma	3.55e-05	0.000205	CcSEcCtD
Sorafenib—Infection—Betamethasone—asthma	3.55e-05	0.000205	CcSEcCtD
Sorafenib—Anaemia—Prednisone—asthma	3.52e-05	0.000203	CcSEcCtD
Sorafenib—Shock—Dexamethasone—asthma	3.52e-05	0.000203	CcSEcCtD
Sorafenib—Shock—Betamethasone—asthma	3.52e-05	0.000203	CcSEcCtD
Sorafenib—Dyspnoea—Triamcinolone—asthma	3.51e-05	0.000202	CcSEcCtD
Sorafenib—Nervous system disorder—Betamethasone—asthma	3.5e-05	0.000202	CcSEcCtD
Sorafenib—Nervous system disorder—Dexamethasone—asthma	3.5e-05	0.000202	CcSEcCtD
Sorafenib—Thrombocytopenia—Dexamethasone—asthma	3.5e-05	0.000202	CcSEcCtD
Sorafenib—Thrombocytopenia—Betamethasone—asthma	3.5e-05	0.000202	CcSEcCtD
Sorafenib—Angioedema—Prednisone—asthma	3.48e-05	0.000201	CcSEcCtD
Sorafenib—Dyspepsia—Triamcinolone—asthma	3.47e-05	0.0002	CcSEcCtD
Sorafenib—Dyspepsia—Methylprednisolone—asthma	3.46e-05	0.000199	CcSEcCtD
Sorafenib—Gastrointestinal pain—Hydrocortisone—asthma	3.42e-05	0.000197	CcSEcCtD
Sorafenib—Syncope—Prednisone—asthma	3.42e-05	0.000197	CcSEcCtD
Sorafenib—Anorexia—Betamethasone—asthma	3.41e-05	0.000196	CcSEcCtD
Sorafenib—Anorexia—Dexamethasone—asthma	3.41e-05	0.000196	CcSEcCtD
Sorafenib—Urticaria—Prednisolone—asthma	3.4e-05	0.000196	CcSEcCtD
Sorafenib—Fatigue—Triamcinolone—asthma	3.4e-05	0.000196	CcSEcCtD
Sorafenib—Fatigue—Methylprednisolone—asthma	3.39e-05	0.000195	CcSEcCtD
Sorafenib—Pain—Triamcinolone—asthma	3.37e-05	0.000194	CcSEcCtD
Sorafenib—Loss of consciousness—Prednisone—asthma	3.35e-05	0.000193	CcSEcCtD
Sorafenib—Urticaria—Hydrocortisone—asthma	3.32e-05	0.000191	CcSEcCtD
Sorafenib—Abdominal pain—Hydrocortisone—asthma	3.31e-05	0.000191	CcSEcCtD
Sorafenib—Body temperature increased—Hydrocortisone—asthma	3.31e-05	0.000191	CcSEcCtD
Sorafenib—Hypertension—Prednisone—asthma	3.29e-05	0.00019	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Betamethasone—asthma	3.26e-05	0.000188	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Dexamethasone—asthma	3.26e-05	0.000188	CcSEcCtD
Sorafenib—Myalgia—Prednisone—asthma	3.25e-05	0.000187	CcSEcCtD
Sorafenib—Arthralgia—Prednisone—asthma	3.25e-05	0.000187	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.22e-05	0.000186	CcSEcCtD
Sorafenib—Gastrointestinal pain—Methylprednisolone—asthma	3.21e-05	0.000185	CcSEcCtD
Sorafenib—Hypersensitivity—Prednisolone—asthma	3.16e-05	0.000182	CcSEcCtD
Sorafenib—Dyspepsia—Betamethasone—asthma	3.15e-05	0.000181	CcSEcCtD
Sorafenib—Dyspepsia—Dexamethasone—asthma	3.15e-05	0.000181	CcSEcCtD
Sorafenib—Urticaria—Triamcinolone—asthma	3.13e-05	0.00018	CcSEcCtD
Sorafenib—Urticaria—Methylprednisolone—asthma	3.12e-05	0.00018	CcSEcCtD
Sorafenib—Body temperature increased—Triamcinolone—asthma	3.11e-05	0.000179	CcSEcCtD
Sorafenib—Anaphylactic shock—Prednisone—asthma	3.11e-05	0.000179	CcSEcCtD
Sorafenib—Abdominal pain—Methylprednisolone—asthma	3.11e-05	0.000179	CcSEcCtD
Sorafenib—Decreased appetite—Betamethasone—asthma	3.11e-05	0.000179	CcSEcCtD
Sorafenib—Decreased appetite—Dexamethasone—asthma	3.11e-05	0.000179	CcSEcCtD
Sorafenib—Infection—Prednisone—asthma	3.09e-05	0.000178	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Dexamethasone—asthma	3.09e-05	0.000178	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Betamethasone—asthma	3.09e-05	0.000178	CcSEcCtD
Sorafenib—Hypersensitivity—Hydrocortisone—asthma	3.08e-05	0.000178	CcSEcCtD
Sorafenib—Fatigue—Betamethasone—asthma	3.08e-05	0.000178	CcSEcCtD
Sorafenib—Fatigue—Dexamethasone—asthma	3.08e-05	0.000178	CcSEcCtD
Sorafenib—Shock—Prednisone—asthma	3.06e-05	0.000176	CcSEcCtD
Sorafenib—Pain—Betamethasone—asthma	3.06e-05	0.000176	CcSEcCtD
Sorafenib—Pain—Dexamethasone—asthma	3.06e-05	0.000176	CcSEcCtD
Sorafenib—Nervous system disorder—Prednisone—asthma	3.05e-05	0.000176	CcSEcCtD
Sorafenib—Skin disorder—Prednisone—asthma	3.02e-05	0.000174	CcSEcCtD
Sorafenib—Asthenia—Hydrocortisone—asthma	3e-05	0.000173	CcSEcCtD
Sorafenib—Anorexia—Prednisone—asthma	2.97e-05	0.000171	CcSEcCtD
Sorafenib—Pruritus—Hydrocortisone—asthma	2.96e-05	0.000171	CcSEcCtD
Sorafenib—Gastrointestinal pain—Dexamethasone—asthma	2.92e-05	0.000168	CcSEcCtD
Sorafenib—Gastrointestinal pain—Betamethasone—asthma	2.92e-05	0.000168	CcSEcCtD
Sorafenib—Hypersensitivity—Triamcinolone—asthma	2.9e-05	0.000167	CcSEcCtD
Sorafenib—Hypersensitivity—Methylprednisolone—asthma	2.9e-05	0.000167	CcSEcCtD
Sorafenib—Diarrhoea—Hydrocortisone—asthma	2.86e-05	0.000165	CcSEcCtD
Sorafenib—Urticaria—Dexamethasone—asthma	2.84e-05	0.000164	CcSEcCtD
Sorafenib—Urticaria—Betamethasone—asthma	2.84e-05	0.000164	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Prednisone—asthma	2.84e-05	0.000163	CcSEcCtD
Sorafenib—Dizziness—Prednisolone—asthma	2.83e-05	0.000163	CcSEcCtD
Sorafenib—Asthenia—Triamcinolone—asthma	2.83e-05	0.000163	CcSEcCtD
Sorafenib—Body temperature increased—Dexamethasone—asthma	2.83e-05	0.000163	CcSEcCtD
Sorafenib—Body temperature increased—Betamethasone—asthma	2.83e-05	0.000163	CcSEcCtD
Sorafenib—Abdominal pain—Dexamethasone—asthma	2.83e-05	0.000163	CcSEcCtD
Sorafenib—Abdominal pain—Betamethasone—asthma	2.83e-05	0.000163	CcSEcCtD
Sorafenib—Asthenia—Methylprednisolone—asthma	2.82e-05	0.000162	CcSEcCtD
Sorafenib—Pruritus—Triamcinolone—asthma	2.79e-05	0.000161	CcSEcCtD
Sorafenib—Pruritus—Methylprednisolone—asthma	2.78e-05	0.00016	CcSEcCtD
Sorafenib—Dizziness—Hydrocortisone—asthma	2.77e-05	0.000159	CcSEcCtD
Sorafenib—Dyspepsia—Prednisone—asthma	2.74e-05	0.000158	CcSEcCtD
Sorafenib—Decreased appetite—Prednisone—asthma	2.71e-05	0.000156	CcSEcCtD
Sorafenib—Rash—Prednisolone—asthma	2.7e-05	0.000156	CcSEcCtD
Sorafenib—Dermatitis—Prednisolone—asthma	2.7e-05	0.000155	CcSEcCtD
Sorafenib—Diarrhoea—Methylprednisolone—asthma	2.69e-05	0.000155	CcSEcCtD
Sorafenib—Fatigue—Prednisone—asthma	2.68e-05	0.000155	CcSEcCtD
Sorafenib—Headache—Prednisolone—asthma	2.68e-05	0.000155	CcSEcCtD
Sorafenib—Constipation—Prednisone—asthma	2.66e-05	0.000153	CcSEcCtD
Sorafenib—Vomiting—Hydrocortisone—asthma	2.66e-05	0.000153	CcSEcCtD
Sorafenib—Rash—Hydrocortisone—asthma	2.64e-05	0.000152	CcSEcCtD
Sorafenib—Dermatitis—Hydrocortisone—asthma	2.63e-05	0.000152	CcSEcCtD
Sorafenib—Headache—Hydrocortisone—asthma	2.62e-05	0.000151	CcSEcCtD
Sorafenib—Dizziness—Triamcinolone—asthma	2.6e-05	0.00015	CcSEcCtD
Sorafenib—Dizziness—Methylprednisolone—asthma	2.6e-05	0.00015	CcSEcCtD
Sorafenib—Asthenia—Betamethasone—asthma	2.56e-05	0.000148	CcSEcCtD
Sorafenib—Asthenia—Dexamethasone—asthma	2.56e-05	0.000148	CcSEcCtD
Sorafenib—Gastrointestinal pain—Prednisone—asthma	2.54e-05	0.000147	CcSEcCtD
Sorafenib—Nausea—Prednisolone—asthma	2.54e-05	0.000147	CcSEcCtD
Sorafenib—Pruritus—Dexamethasone—asthma	2.53e-05	0.000146	CcSEcCtD
Sorafenib—Pruritus—Betamethasone—asthma	2.53e-05	0.000146	CcSEcCtD
Sorafenib—Vomiting—Triamcinolone—asthma	2.5e-05	0.000144	CcSEcCtD
Sorafenib—Vomiting—Methylprednisolone—asthma	2.5e-05	0.000144	CcSEcCtD
Sorafenib—Nausea—Hydrocortisone—asthma	2.48e-05	0.000143	CcSEcCtD
Sorafenib—Rash—Triamcinolone—asthma	2.48e-05	0.000143	CcSEcCtD
Sorafenib—Dermatitis—Triamcinolone—asthma	2.48e-05	0.000143	CcSEcCtD
Sorafenib—Rash—Methylprednisolone—asthma	2.48e-05	0.000143	CcSEcCtD
Sorafenib—Dermatitis—Methylprednisolone—asthma	2.48e-05	0.000143	CcSEcCtD
Sorafenib—Urticaria—Prednisone—asthma	2.47e-05	0.000142	CcSEcCtD
Sorafenib—Headache—Triamcinolone—asthma	2.47e-05	0.000142	CcSEcCtD
Sorafenib—Headache—Methylprednisolone—asthma	2.46e-05	0.000142	CcSEcCtD
Sorafenib—Abdominal pain—Prednisone—asthma	2.46e-05	0.000142	CcSEcCtD
Sorafenib—Body temperature increased—Prednisone—asthma	2.46e-05	0.000142	CcSEcCtD
Sorafenib—Diarrhoea—Betamethasone—asthma	2.45e-05	0.000141	CcSEcCtD
Sorafenib—Diarrhoea—Dexamethasone—asthma	2.45e-05	0.000141	CcSEcCtD
Sorafenib—Dizziness—Betamethasone—asthma	2.36e-05	0.000136	CcSEcCtD
Sorafenib—Dizziness—Dexamethasone—asthma	2.36e-05	0.000136	CcSEcCtD
Sorafenib—Nausea—Triamcinolone—asthma	2.34e-05	0.000135	CcSEcCtD
Sorafenib—Nausea—Methylprednisolone—asthma	2.33e-05	0.000134	CcSEcCtD
Sorafenib—Hypersensitivity—Prednisone—asthma	2.29e-05	0.000132	CcSEcCtD
Sorafenib—Vomiting—Betamethasone—asthma	2.27e-05	0.000131	CcSEcCtD
Sorafenib—Vomiting—Dexamethasone—asthma	2.27e-05	0.000131	CcSEcCtD
Sorafenib—Rash—Dexamethasone—asthma	2.25e-05	0.00013	CcSEcCtD
Sorafenib—Rash—Betamethasone—asthma	2.25e-05	0.00013	CcSEcCtD
Sorafenib—Dermatitis—Dexamethasone—asthma	2.25e-05	0.00013	CcSEcCtD
Sorafenib—Dermatitis—Betamethasone—asthma	2.25e-05	0.00013	CcSEcCtD
Sorafenib—Headache—Dexamethasone—asthma	2.24e-05	0.000129	CcSEcCtD
Sorafenib—Headache—Betamethasone—asthma	2.24e-05	0.000129	CcSEcCtD
Sorafenib—Asthenia—Prednisone—asthma	2.23e-05	0.000129	CcSEcCtD
Sorafenib—Pruritus—Prednisone—asthma	2.2e-05	0.000127	CcSEcCtD
Sorafenib—Diarrhoea—Prednisone—asthma	2.13e-05	0.000123	CcSEcCtD
Sorafenib—Nausea—Dexamethasone—asthma	2.12e-05	0.000122	CcSEcCtD
Sorafenib—Nausea—Betamethasone—asthma	2.12e-05	0.000122	CcSEcCtD
Sorafenib—Dizziness—Prednisone—asthma	2.06e-05	0.000119	CcSEcCtD
Sorafenib—Vomiting—Prednisone—asthma	1.98e-05	0.000114	CcSEcCtD
Sorafenib—Rash—Prednisone—asthma	1.96e-05	0.000113	CcSEcCtD
Sorafenib—Dermatitis—Prednisone—asthma	1.96e-05	0.000113	CcSEcCtD
Sorafenib—Headache—Prednisone—asthma	1.95e-05	0.000112	CcSEcCtD
Sorafenib—Nausea—Prednisone—asthma	1.85e-05	0.000107	CcSEcCtD
Sorafenib—PDGFRB—Immune System—EGFR—asthma	1.78e-06	1.25e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—NQO1—asthma	1.78e-06	1.25e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ITPR1—asthma	1.78e-06	1.24e-05	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL6—asthma	1.78e-06	1.24e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PTGS2—asthma	1.78e-06	1.24e-05	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PTGS2—asthma	1.78e-06	1.24e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CCL2—asthma	1.77e-06	1.24e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NOS3—asthma	1.77e-06	1.24e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TGFB1—asthma	1.77e-06	1.24e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—SERPINE1—asthma	1.77e-06	1.24e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—IL6R—asthma	1.77e-06	1.24e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PPP2CA—asthma	1.76e-06	1.24e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—IL2—asthma	1.76e-06	1.23e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—IL2—asthma	1.76e-06	1.23e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—NQO1—asthma	1.76e-06	1.23e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CAT—asthma	1.76e-06	1.23e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CXCL8—asthma	1.75e-06	1.23e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CXCL8—asthma	1.75e-06	1.22e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—STAT3—asthma	1.74e-06	1.22e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ADCY2—asthma	1.74e-06	1.22e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—EGFR—asthma	1.74e-06	1.22e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—EGFR—asthma	1.73e-06	1.21e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ADCY2—asthma	1.72e-06	1.21e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ALB—asthma	1.72e-06	1.21e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—FN1—asthma	1.72e-06	1.2e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.71e-06	1.2e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—RHOA—asthma	1.71e-06	1.2e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ALB—asthma	1.71e-06	1.2e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NOS3—asthma	1.69e-06	1.18e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—TGFB1—asthma	1.67e-06	1.17e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—IL2—asthma	1.67e-06	1.17e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	1.67e-06	1.17e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—IL2—asthma	1.67e-06	1.17e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MMP9—asthma	1.67e-06	1.17e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MMP9—asthma	1.67e-06	1.17e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—VEGFA—asthma	1.66e-06	1.16e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GSTM1—asthma	1.66e-06	1.16e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PLA2G4A—asthma	1.66e-06	1.16e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PTEN—asthma	1.66e-06	1.16e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PTEN—asthma	1.66e-06	1.16e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—SERPINE1—asthma	1.66e-06	1.16e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—NOS3—asthma	1.65e-06	1.15e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—VEGFA—asthma	1.65e-06	1.15e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—STAT3—asthma	1.64e-06	1.15e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—EGFR—asthma	1.64e-06	1.15e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	1.64e-06	1.15e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—NOS3—asthma	1.63e-06	1.14e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—STAT3—asthma	1.63e-06	1.14e-05	CbGpPWpGaD
Sorafenib—BRAF—Disease—IL6—asthma	1.63e-06	1.14e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GSTP1—asthma	1.61e-06	1.13e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—STAT3—asthma	1.61e-06	1.13e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ALOX5—asthma	1.61e-06	1.13e-05	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL6—asthma	1.6e-06	1.12e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL6—asthma	1.6e-06	1.12e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—RHOA—asthma	1.6e-06	1.12e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—HMOX1—asthma	1.59e-06	1.11e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ITPR1—asthma	1.59e-06	1.11e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—EGFR—asthma	1.58e-06	1.11e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MMP9—asthma	1.58e-06	1.11e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NOS3—asthma	1.58e-06	1.11e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MMP9—asthma	1.58e-06	1.11e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PTEN—asthma	1.57e-06	1.1e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GSTP1—asthma	1.57e-06	1.1e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CXCL8—asthma	1.57e-06	1.1e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PTEN—asthma	1.57e-06	1.1e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CAT—asthma	1.57e-06	1.1e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—POMC—asthma	1.56e-06	1.1e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—HMOX1—asthma	1.55e-06	1.09e-05	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PTEN—asthma	1.55e-06	1.09e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PTEN—asthma	1.55e-06	1.09e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ITPR1—asthma	1.55e-06	1.08e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CARM1—asthma	1.53e-06	1.07e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CAT—asthma	1.53e-06	1.07e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CCL2—asthma	1.53e-06	1.07e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PPP2CA—asthma	1.53e-06	1.07e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—IL6R—asthma	1.53e-06	1.07e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TGFB1—asthma	1.52e-06	1.07e-05	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL6—asthma	1.52e-06	1.07e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL6—asthma	1.52e-06	1.06e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—DCN—asthma	1.51e-06	1.06e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TGFB1—asthma	1.51e-06	1.06e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PTGS2—asthma	1.51e-06	1.06e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NQO1—asthma	1.51e-06	1.05e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—IL2—asthma	1.5e-06	1.05e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CXCL8—asthma	1.5e-06	1.05e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—VEGFA—asthma	1.5e-06	1.05e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—VEGFA—asthma	1.5e-06	1.05e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—EGFR—asthma	1.5e-06	1.05e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—EGFR—asthma	1.49e-06	1.05e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PTGS2—asthma	1.49e-06	1.05e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—TGFB1—asthma	1.49e-06	1.05e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	1.49e-06	1.04e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—STAT3—asthma	1.48e-06	1.04e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—STAT3—asthma	1.48e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GSTP1—asthma	1.48e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PLA2G4A—asthma	1.48e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GSTM1—asthma	1.48e-06	1.04e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—EGFR—asthma	1.48e-06	1.04e-05	CbGpPWpGaD
Sorafenib—KIT—Disease—IL6—asthma	1.48e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ADCY2—asthma	1.47e-06	1.03e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ALDH2—asthma	1.47e-06	1.03e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GSTP1—asthma	1.47e-06	1.03e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—EGFR—asthma	1.46e-06	1.02e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—HMOX1—asthma	1.46e-06	1.02e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.46e-06	1.02e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ITPR1—asthma	1.46e-06	1.02e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—HMOX1—asthma	1.45e-06	1.02e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ITPR1—asthma	1.45e-06	1.01e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GSTM1—asthma	1.45e-06	1.01e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PLA2G4A—asthma	1.45e-06	1.01e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CAT—asthma	1.44e-06	1.01e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—IL2—asthma	1.43e-06	1e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CAT—asthma	1.43e-06	1e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—SERPINE1—asthma	1.43e-06	1e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—IL6—asthma	1.43e-06	9.99e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MMP9—asthma	1.42e-06	9.96e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—VEGFA—asthma	1.42e-06	9.96e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—VEGFA—asthma	1.42e-06	9.93e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PTEN—asthma	1.41e-06	9.91e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—STAT3—asthma	1.41e-06	9.86e-06	CbGpPWpGaD
Sorafenib—FGFR1—Disease—IL6—asthma	1.4e-06	9.83e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—STAT3—asthma	1.4e-06	9.83e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CXCL8—asthma	1.4e-06	9.82e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—IL6—asthma	1.4e-06	9.81e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GSTT1—asthma	1.4e-06	9.8e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—POMC—asthma	1.39e-06	9.71e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—RHOA—asthma	1.38e-06	9.66e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TGFB1—asthma	1.37e-06	9.63e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TGFB1—asthma	1.37e-06	9.63e-06	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—IL6—asthma	1.37e-06	9.6e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL6—asthma	1.37e-06	9.57e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PPP2CA—asthma	1.36e-06	9.56e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NOS3—asthma	1.36e-06	9.56e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PLA2G4A—asthma	1.36e-06	9.54e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GSTM1—asthma	1.36e-06	9.54e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MMP9—asthma	1.36e-06	9.5e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—POMC—asthma	1.35e-06	9.49e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GSTM1—asthma	1.35e-06	9.46e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PLA2G4A—asthma	1.35e-06	9.46e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PTEN—asthma	1.35e-06	9.45e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—EGFR—asthma	1.35e-06	9.44e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—EGFR—asthma	1.35e-06	9.44e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—IL2—asthma	1.34e-06	9.38e-06	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—IL6—asthma	1.34e-06	9.36e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—IL6—asthma	1.33e-06	9.34e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PPP2CA—asthma	1.33e-06	9.33e-06	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PTEN—asthma	1.31e-06	9.21e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TGFB1—asthma	1.3e-06	9.14e-06	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PTEN—asthma	1.3e-06	9.13e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TGFB1—asthma	1.3e-06	9.12e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—EGFR—asthma	1.28e-06	8.96e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—VEGFA—asthma	1.28e-06	8.95e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—EGFR—asthma	1.28e-06	8.94e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	1.27e-06	8.93e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MMP9—asthma	1.27e-06	8.88e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—STAT3—asthma	1.26e-06	8.86e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ALB—asthma	1.26e-06	8.85e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—IL6—asthma	1.26e-06	8.84e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PTEN—asthma	1.26e-06	8.83e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GSTP1—asthma	1.26e-06	8.8e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PPP2CA—asthma	1.25e-06	8.79e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PPP2CA—asthma	1.24e-06	8.71e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—HMOX1—asthma	1.24e-06	8.68e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ITPR1—asthma	1.24e-06	8.66e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ALB—asthma	1.23e-06	8.65e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CAT—asthma	1.22e-06	8.56e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—VEGFA—asthma	1.22e-06	8.53e-06	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL6—asthma	1.22e-06	8.53e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CXCL8—asthma	1.21e-06	8.48e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—NOS3—asthma	1.21e-06	8.46e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—STAT3—asthma	1.21e-06	8.45e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—NOS3—asthma	1.18e-06	8.27e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—POMC—asthma	1.17e-06	8.22e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TGFB1—asthma	1.17e-06	8.21e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NQO1—asthma	1.16e-06	8.14e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—IL2—asthma	1.16e-06	8.1e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PLA2G4A—asthma	1.15e-06	8.09e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GSTM1—asthma	1.15e-06	8.09e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—IL6—asthma	1.15e-06	8.06e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—EGFR—asthma	1.15e-06	8.05e-06	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—IL6—asthma	1.15e-06	8.05e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—VEGFA—asthma	1.14e-06	7.98e-06	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—IL6—asthma	1.14e-06	7.97e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ADCY2—asthma	1.14e-06	7.97e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—STAT3—asthma	1.13e-06	7.9e-06	CbGpPWpGaD
Sorafenib—RAF1—Disease—IL6—asthma	1.12e-06	7.88e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TGFB1—asthma	1.12e-06	7.83e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTGS2—asthma	1.11e-06	7.74e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—EGFR—asthma	1.1e-06	7.68e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MMP9—asthma	1.09e-06	7.67e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PTEN—asthma	1.09e-06	7.62e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTGS2—asthma	1.08e-06	7.57e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ALB—asthma	1.07e-06	7.49e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PPP2CA—asthma	1.06e-06	7.45e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—POMC—asthma	1.05e-06	7.33e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TGFB1—asthma	1.04e-06	7.32e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—IL6—asthma	1.04e-06	7.26e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—IL6—asthma	1.04e-06	7.26e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—EGFR—asthma	1.02e-06	7.18e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—NOS3—asthma	1.02e-06	7.17e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—POMC—asthma	1.02e-06	7.16e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—IL6—asthma	9.83e-07	6.89e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—VEGFA—asthma	9.83e-07	6.88e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—IL6—asthma	9.81e-07	6.87e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—STAT3—asthma	9.73e-07	6.82e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GSTP1—asthma	9.69e-07	6.79e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTEN—asthma	9.64e-07	6.75e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—POMC—asthma	9.63e-07	6.75e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—HMOX1—asthma	9.56e-07	6.7e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—POMC—asthma	9.55e-07	6.69e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ALB—asthma	9.55e-07	6.69e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ITPR1—asthma	9.54e-07	6.68e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CAT—asthma	9.43e-07	6.61e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTEN—asthma	9.42e-07	6.6e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTGS2—asthma	9.36e-07	6.55e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ALB—asthma	9.32e-07	6.53e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—NOS3—asthma	9.13e-07	6.4e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TGFB1—asthma	9.02e-07	6.32e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—NOS3—asthma	8.91e-07	6.24e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PLA2G4A—asthma	8.91e-07	6.24e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GSTM1—asthma	8.91e-07	6.24e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—EGFR—asthma	8.84e-07	6.2e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—IL6—asthma	8.83e-07	6.19e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ALB—asthma	8.78e-07	6.15e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ALB—asthma	8.7e-07	6.1e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—IL6—asthma	8.43e-07	5.9e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—NOS3—asthma	8.4e-07	5.88e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTGS2—asthma	8.35e-07	5.85e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—NOS3—asthma	8.33e-07	5.83e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PPP2CA—asthma	8.2e-07	5.75e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTEN—asthma	8.16e-07	5.72e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—POMC—asthma	8.16e-07	5.71e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTGS2—asthma	8.15e-07	5.71e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—IL6—asthma	7.87e-07	5.52e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTGS2—asthma	7.68e-07	5.38e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTGS2—asthma	7.62e-07	5.33e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ALB—asthma	7.44e-07	5.21e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTEN—asthma	7.28e-07	5.1e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NOS3—asthma	7.11e-07	4.98e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTEN—asthma	7.11e-07	4.98e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—IL6—asthma	6.8e-07	4.76e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTEN—asthma	6.7e-07	4.69e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTEN—asthma	6.64e-07	4.65e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTGS2—asthma	6.51e-07	4.56e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—POMC—asthma	6.3e-07	4.41e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ALB—asthma	5.74e-07	4.02e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTEN—asthma	5.68e-07	3.98e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NOS3—asthma	5.49e-07	3.85e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTGS2—asthma	5.02e-07	3.52e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTEN—asthma	4.38e-07	3.07e-06	CbGpPWpGaD
